logo-loader
viewScapa Group PLC

Scapa Group says full year results are ahead of expectations

Scapa expects to achieve further progress through organic growth, efficiency improvements and acquisitions

health
Scapa's healthcare division delivered a 5.0% increase in annual revenue

Scapa Group plc (LON:SCPA) said full year results are ahead of expectations following a strong trading performance.

Shares rose 8.25% to 400.0p in morning trading.

The company, which supplies bonding solutions and adhesive-based products to the healthcare and industrial markets, said revenue, trading profit and margins will beat estimates for the year.

Its healthcare division saw revenue rise 16.5% or 5.0% at constant exchange rates, including a contribution from US wound-care supplier EuroMed Inc, which the group bought last May for US$35mln.

Margins in healthcare will exceed 15% for the year following an improvement in the second half, bolstered by efficiency improvement programmes and growth in higher margin turn key products.

Industrial margin is expected to reach “double digits” for the year thanks to asset rationalisation and lower material costs, Scapa said.

"We have delivered another set of strong results which are ahead of expectations as we continue to execute our strategies for Healthcare and Industrial,” said chief executive Heejae Chae.  

“We remain confident of achieving further progress through organic growth, efficiency improvements and acquisitions."

Quick facts: Scapa Group PLC

Price: 90.6 GBX

AIM:SCPA
Market: AIM
Market Cap: £169.01 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian Vanadium confirms ‘exceptional’ vanadium extraction in test work

Australian Vanadium Ltd (ASX:AVL) (OTCMKTS:ATVVF) managing director Vincent Algar speaks to Proactive about recent pilot test-work conducted at the Australian Vanadium Project, which delivered leach extraction of up to 94.7%. The pilot-scale roast and leach testing has confirmed the...

1 day, 17 hours ago

2 min read